Using Best–Worst Scaling to Investigate Preferences in Health Care Kei Long CheungBen F. M. WijnenMickael Hiligsmann Systematic Review Open access 11 July 2016 Pages: 1195 - 1209
Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review Surasak SaokaewAjaree RayanakornNathorn Chaiyakunapruk Systematic Review 10 August 2016 Pages: 1211 - 1225
The Value of Medicines: A Crucial but Vague Concept Fernando AntoñanzasRobert TerkolaMaarten Postma Review Article 21 July 2016 Pages: 1227 - 1239
Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Rachid RafiaAlison ScopeAlan Lobo Review Article 01 August 2016 Pages: 1241 - 1253
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study Pei-Jung LinCayla J. SaretJoshua T. Cohen Original Research Article 26 July 2016 Pages: 1255 - 1265
The Pharmacoeconomic Evaluation Process in Ireland Laura McCullaghMichael Barry Original Research Article 29 July 2016 Pages: 1267 - 1276
Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases Paul S. J. MillerHarry HillFredrik L. Andersson Original Research Article 31 August 2016 Pages: 1277 - 1297
Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model Christiaan DolkMartin EichnerMaarten Postma Original Research Article Open access 19 September 2016 Pages: 1299 - 1308